Echocardiography

Windtree Hosting Key Opinion Leader Webinar on Istaroxime for the Treatment of Acute Heart Failure and the Upcoming Data in Early Cardiogenic Shock

Thursday, October 14, 2021 - 12:30pm

Additionally, Windtree will discuss its development program for istaroxime in early cardiogenic shock, which is currently in a Phase 2 study with targeted completion in Q4 2021.

Key Points: 
  • Additionally, Windtree will discuss its development program for istaroxime in early cardiogenic shock, which is currently in a Phase 2 study with targeted completion in Q4 2021.
  • (UK) is Director of Heart Failure and of the Echocardiography Laboratory at the San Francisco Veterans Affairs Medical Center in San Francisco, California.
  • He also currently serves on the Acute Heart Failure Committee of the European Society of Cardiology Heart Failure Association and has served on the National Committee on Heart Failure and Transplantation of the American Heart Association.
  • Windtree Therapeutics, Inc.is advancing multiple late-stage interventions for acute cardiovascular and acute pulmonary disorders to treat patients in moments of crisis.

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

Monday, October 11, 2021 - 2:29am

Since December 2019, Fujitsu has been making progress with research and development of proprietary AI technology(2) in collaboration with the University of Tokyo Hospital.

Key Points: 
  • Since December 2019, Fujitsu has been making progress with research and development of proprietary AI technology(2) in collaboration with the University of Tokyo Hospital.
  • The AI will be used in clinical field research to estimate the presence or absence of abnormal heart movements based on the data of patients undergoing electrocardiographic procedures at the University of Tokyo Hospital.
  • Based on the electrocardiogram data of patients examined at the University of Tokyo Hospital, Fujitsu and the University of Tokyo Hospital will verify the effectiveness of detection of abnormal heart movement by AI.
  • Through its joint research with the University of Tokyo Hospital, Fujitsu will continue to actively promote research and development of AI to detect various heart diseases.

Doctors Predict Benefits of Ultrasound Enhancing Agents

Friday, October 1, 2021 - 12:13am

Doctors today described new ways to predict whether specific patients will benefit from the use of ultrasound enhancing agents (UEAs) to improve the accuracy of their ultrasound scan for diagnosis of heart disease, the number one killer of Americans.

Key Points: 
  • Doctors today described new ways to predict whether specific patients will benefit from the use of ultrasound enhancing agents (UEAs) to improve the accuracy of their ultrasound scan for diagnosis of heart disease, the number one killer of Americans.
  • Dr. Strom also is a member of the board of directors of the International Contrast Ultrasound Society (ICUS).
  • Doctors also were encouraged to use UEAs to enhance ultrasound images of carotid arteries.
  • UEAs (sometimes also known as ultrasound contrast agents) are injected during an ultrasound scan to enhance the resolution of an ultrasound image of the heart and other organ systems.

UltraSight Collaboration with GE Healthcare will bring Wireless Cardiac Point of Care Ultrasound to Space

Thursday, September 30, 2021 - 2:00pm

We are excited to collaborate with GE Healthcare and lead a new wave of medical innovation in space."

Key Points: 
  • We are excited to collaborate with GE Healthcare and lead a new wave of medical innovation in space."
  • In May 2021, UltraSight was selected by the Israel Space Agency to conduct the cardiac study aboard the 'Rakia' space mission.
  • This is not the first time a GE Healthcare ultrasound device was used in space.
  • The UltraSight automated guidance system and advanced usability features help bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.

Gwinnett Technical College Partners with Mindray North America for High-Tech Ultrasound Education

Thursday, August 26, 2021 - 3:00pm

MAHWAH, N.J., Aug. 26, 2021 /PRNewswire-PRWeb/ --To better prepare its Cardiovascular Echocardiography students to thrive in the evolving healthcare environment, Gwinnett Technical College (Gwinnett Tech) has partnered with Mindray North America to enhance department and education capabilities with seven new DC-90 Ultrasound Systems .

Key Points: 
  • MAHWAH, N.J., Aug. 26, 2021 /PRNewswire-PRWeb/ --To better prepare its Cardiovascular Echocardiography students to thrive in the evolving healthcare environment, Gwinnett Technical College (Gwinnett Tech) has partnered with Mindray North America to enhance department and education capabilities with seven new DC-90 Ultrasound Systems .
  • With the increased demand for cardiac sonographers, Gwinnett Tech is uniquely positioned to help students succeed as Georgia's second-largest technical college.
  • They are extremely user friendly, and the imaging quality is superb," said Lead Instructor of Echocardiography at Gwinnett Technical College, Kathy Johnson.
  • Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey.

Philips spotlights smart diagnostic and treatment solutions driving clinical confidence and workflow efficiency at ESC 2021

Thursday, August 26, 2021 - 9:00am

Technology highlights in diagnostic and treatment solutions at this years virtual ESC congress include:

Key Points: 
  • Technology highlights in diagnostic and treatment solutions at this years virtual ESC congress include:
    Philips Spectral CT 7500 for advanced cardiac imaging.
  • Philips new echo imaging, quantification, and tele-health technologies help improve clinical confidence, automate repetitive tasks, and remotely and securely connect clinicians and patients.
  • Philips cardiology informatics solutions, smart intelligent algorithms and predictive analytics work seamlessly to help optimize patient throughput.
  • Visit the Philips ESC Engagement Hub for the full list of Philips hosted webinars throughout the event.

EchoNous Partners with Us2.ai for Machine Learning-enabled Analysis of Heart Scans

Thursday, August 5, 2021 - 5:00pm

Us2.ais software is being integrated into EchoNouss Kosmos Platform, enabling automated analysis of heart structures that are scanned with Kosmos; saving work flow time and improving accuracy.

Key Points: 
  • Us2.ais software is being integrated into EchoNouss Kosmos Platform, enabling automated analysis of heart structures that are scanned with Kosmos; saving work flow time and improving accuracy.
  • The Us2.ai partnership with EchoNous is exclusive Kosmos will be the only device in its size category to carry the software.
  • By integrating our software into EchoNous devices, were combining our AI-driven analysis with Kosmos superior imaging quality and mobility.
  • Its flagship device, Kosmos, offers diagnostic-quality heart, lung, and abdominal scans in a handheld tool.

Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro

Thursday, July 1, 2021 - 2:00pm

Used together with Philips Premium Cardiology Ultrasound System (EPIQ CVx), the real-time 3D Philips Intracardiac Echocardiography Catheter VeriSight Pro offers superior 2D and 3D live image guidance for a wide range of procedures in structural heart disease and electrophysiology, allowing interventionalists to navigate procedures with ease, provide superior care, and optimize cath lab performance.

Key Points: 
  • Used together with Philips Premium Cardiology Ultrasound System (EPIQ CVx), the real-time 3D Philips Intracardiac Echocardiography Catheter VeriSight Pro offers superior 2D and 3D live image guidance for a wide range of procedures in structural heart disease and electrophysiology, allowing interventionalists to navigate procedures with ease, provide superior care, and optimize cath lab performance.
  • For interventional cardiologists, VeriSight Pro delivers a good alternative high quality 3D live image to TEE, including 3D Volume and Color Flow imaging.
  • Philips Intracardiac Echocardiology Catheter VeriSight Pro is designed to be used with Philips Premium Cardiology Ultrasound System (EPIQ CVx) .
  • Philips Intracardiac Echocardiology Catheter VeriSight Pro is available on a limited basis in the U.S.

Caption Health's AI-Guided Ultrasound Deployed in U.S. Navy's CHARM 2.0 Study to Evaluate Cardiac Impact of COVID-19

Tuesday, May 11, 2021 - 11:00am

"However, it typically requires extensive training to be able to adequately acquire and interpret images.

Key Points: 
  • "However, it typically requires extensive training to be able to adequately acquire and interpret images.
  • With Caption AI, Navy Medicine can deploy cardiac ultrasound at scale and put the power to capture and interpret these images into the hands of Corpsmen.
  • This will allow not only the U.S. Navy, but the world, to have a better understanding of the cardiovascular impact of COVID-19.
  • The world\'s first and only FDA cleared AI-guided ultrasound system, Caption AI, empowers healthcare providers with new capabilities to acquire and interpret ultrasound exams.

DiA Imaging Analysis Partners with SonoScape Medical Corporation to Deliver Cardiac Ultrasound AI solutions

Tuesday, May 11, 2021 - 2:00am

b'BE\'ER SHEVA,Israel, andSHENZHEN,China, May 11, 2021 /PRNewswire/ -- DiA Imaging Analysis Ltd. (DiA), a leading provider of AI-powered ultrasound analysis solutions today announced that it has partnered with SonoScape Medical Corporation ( 300633.SZ ), a leading developer and manufacturer of ultrasound systems.

Key Points: 
  • b'BE\'ER SHEVA,Israel, andSHENZHEN,China, May 11, 2021 /PRNewswire/ -- DiA Imaging Analysis Ltd. (DiA), a leading provider of AI-powered ultrasound analysis solutions today announced that it has partnered with SonoScape Medical Corporation ( 300633.SZ ), a leading developer and manufacturer of ultrasound systems.
  • "By joining hands with DiA, we will enhance our users\' capabilities with the most innovative technology of cardiac ultrasound AI tools.
  • "Combining SonoScape\'s ultrasound capacities with DiA\'s AI technology is another great step forward to makethe analysis of ultrasound images smarter and accessible to all.
  • "\nDiA Imaging Analysis is a leading provider of AI-powered ultrasound analysis solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all.